Progression of coronary artery calcification is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall Study

Journal of Diabetes and its Complications

Volumn 31, Issue 1, 2017, Pages 234-240

  Kowall, Bernd ^a   Lehmann, Nils ^b   Mahabadi, Amir Abbas ^b   Moebus, Susanne ^b   Budde, Thomas ^c   Seibel, Rainer ^d   Grönemeyer, Dietrich ^e   Erbel, Raimund ^b   Jöckel, Karl Heinz ^b   Stang, Andreas ^a,f  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Alfred Krupp Hospital   (Germany)

^d Diagnosticum Mülheim   (Germany)

^e UNIVERSITY OF WITTEN HERDECKE   (Germany)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Coronary artery calcification; Coronary artery calcium; Glycemic control; HbA1c; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY CALCIFICATION; CROSS-SECTIONAL STUDY; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTRON BEAM TOMOGRAPHY; FEMALE; FOLLOW UP; GERMANY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; BLOOD; BLOOD VESSEL CALCIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIABETIC ANGIOPATHY; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; HYPERGLYCEMIA; HYPOGLYCEMIA; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RISK FACTOR;

AGED; COHORT STUDIES; COMPUTED TOMOGRAPHY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GERMANY; GLYCATED HEMOGLOBIN A; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR CALCIFICATION;

EID: 84994505178     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2016.08.011     Document Type: Article

References (42)

1. American Diabetes Association, Standards of medical care in diabetes – 2016. Glycemic targets. Diabetes Care 39:Suppl. 1 (2016), S39–S46.
2. American Diabetes Association, Standards of medical care in diabetes – 2016. Classification and diagnosis of diabetes. Diabetes Care 39:Suppl. 1 (2016), S13–S22.
3. Anand, D.V., Lim, E., Darko, D., Bassett, P., Hopkins, D., Lipkin, D., Lahiri, A., Determinants of progression of coronary artery calcification in type 2 diabetes. Journal of the American College of Cardiology 50 (2007), 2218–2225.
4. Blaha, M.J., DeFilippis, A.P., Rivera, J.J., Budoff, M.J., Blankstein, R., Agatston, A., Nasir, K., The relationship between insulin resistance and progression of coronary artery calcification: The multi-ethnic study of atherosclerosis (MESA. Diabetes Care 34 (2011), 749–751.
5. Budoff, M.J., Young, R., Lopez, V.A., Kronmal, R.A., Nasir, K., Blumenthal, R.S., Wong, N.D., Progression of coronary calcium and incident coronary heart disease events: The Multi-Ethnic Study of Atherosclerosis. Journal of the American College of Cardiology 61 (2013), 1231–1239.
6. Budoff, M.J., Yu, D., Nasir, K., Mehrotra, R., Chen, L., Takasu, J., Blumenthal, R.S., Diabetes and progression of coronary calcium under the influence of statin therapy. American Heart Journal 149 (2005), 695–700.
7. Carson, A.P., Steffes, M.W., Carr, J.J., Kim, Y., Gross, M.D., Carnethon, M.R., Lewis, C.E., Hemoglobin A1c and the progression of coronary artery calcification among adults without diabetes. Diabetes Care 38 (2015), 66–71.
8. Chang, Y., Yun, K.E., Jung, H.S., Kim, C.W., Kwon, M.J., Sung, E., Ryu, S., A1C and coronary artery calcification in nondiabetic men and women. Arteriosclerosis, Thrombosis, and Vascular Biology 33 (2013), 2026–2031.
9. Detrano, R.C., Anderson, M., Nelson, J., Wong, N.D., Carr, J.J., McNitt-Gray, M., Bild, D.E., Coronary calcium measurements: Effect of CT scanner type and calcium measure on rescan reproducibility – MESA study. Radiology 236 (2005), 477–484.
10. Erbel, R., Lehmann, N., Churzidse, S., Rauwolf, M., Mahabadi, A.A., Möhlenkamp, S., Jöckel, K.H., Progression of coronary artery calcification seems to be inevitable, but predictable – results of the Heinz Nixdorf Recall (HNR) study. European Heart Journal 35 (2014), 2960–2971.
11. Erbel, R., Möhlenkamp, S., Moebus, S., Schmermund, A., Lehmann, N., Stang, A., Jöckel, K.H., Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: The Heinz Nixdorf Recall study. Journal of the American College of Cardiology 56 (2010), 1397–1406.
12. Ford, E.S., Zhao, G., Li, C., Pre-diabetes and the risk for cardiovascular disease. A systematic review of the evidence. Journal of the American College of Cardiology 55 (2010), 1310–1317.
13. International Expert Committee, International expert committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 32 (2009), 1327–1334.
14. Jöckel, K.H., Lehmann, N., Jaeger, B.R., Moebus, S., Möhlenkamp, S., Schmermund, A., Erbel, R., Smoking cessation and subclinical atherosclerosis – results from the Heinz Nixdorf Recall study. Atherosclerosis 203 (2009), 221–227.
15. Joshi, P.H., Patel, B., Blaha, M.J., Berry, J.D., Blankstein, R., Budoff, M.J., Nasir, K., Coronary artery calcium predicts cardiovascular events in participants with a low lifetime risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis (MESA. Atherosclerosis 246 (2016), 367–373.
16. Kara, K., Mahabadi, A.A., Berg, M.H., Lehmann, N., Möhlenkamp, S., Kälsch, H., Erbel, R., Predicting risk of coronary events and all-cause mortality: Role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall study, European Journal of. Preventive Cardiology 21 (2014), 1171–1179.
17. Kowall, B., Rathmann, W., HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?, Diabetes Metabolism Syndrome. Obesity 6 (2013), 477–491.
18. Lash, T.L., Heuristic thinking and inference from observational epidemiology. Epidemiology 18 (2007), 67–72.
19. Lee, K.K., Fortmann, S.P., Fair, J.M., Iribarren, C., Rubin, G.D., Varady, A., Hlatky, M.A., Insulin resistance independently predicts the progression of coronary artery calcification. American Heart Journal 157 (2009), 939–945.
20. Mahabadi, A.A., Lehmann, N., Dykun, I., Müller, T., Kälsch, H., Erbel, R., Progression of coronary artery calcification by cardiac computed tomography. Herz 40 (2015), 863–868.
21. McCance, D.R., Hanson, R.L., Charles, M.A., Jacobsson, L.T., Pettitt, D.J., Bennett, P.H., Knowler, W.C., Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308 (1994), 1323–1328.
22. McNelly, M.J., McClelland, R.L., Bild, D.E., D.R., J. Jr., Tracy, R.P., Cushman, M., Siscovick, D.S., The association between A1c and subclinical cardiovascular disease. Diabetes Care 32 (2009), 1727–1733.
23. Meigs, J.B., Larson, M.G., D'Agostino, R.B., Levy, D., Clouse, M.E., Nathan, D.M., O´Donnell, C.J., Coronary artery calcification in type 2 diabetes and insulin resistance. The Framingham Offspring study. Diabetes Care 25 (2002), 1313–1319.
24. Moebus, S., Stang, A., Möhlenkamp, S., Dragano, N., Schmermund, A., Slomiany, U., Jöckel, K.H., Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort – results of the Heinz Nixdorf Recall study. Diabetologia 52 (2009), 81–89.
25. Möhlenkamp, S., Lehmann, N., Moebus, S., Schmermund, A., Dragano, N., Stang, A., Erbel, R., Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality. Journal of the American College of Cardiology 57 (2011), 1455–1464.
26. Rhee, E.J., Kim, J.H., Park, H.J., Park, S.E., Oh, H.G., Park, C.Y., Park, S.W., Increased risk for development of coronary artery calcification in insulin-resistant subjects who developed diabetes: 4-year longitudinal study. Atherosclerosis 245 (2016), 132–138.
27. Rutter, M.K., Massaro, J.M., Hoffmann, U., O′Donnell, C.J., Fox, C.S., Fasting glucose, obesity, and coronary artery calcification in community-based people without diabetes. Diabetes Care 35 (2012), 1944–1950.
28. Santos-Oliveira, R., Purdy, C., da Silva, M.P., dos Anjos Carneiro-Leão, A.M., Machado, M., Einarson, T.R., Haemoglobin A1c levels and subsequent cardiovascular disease in persons without diabetes: A meta-analysis of prospective cohorts. Diabetologia 54 (2011), 1327–1334.
29. Sarwar, N., Aspelund, T., Eiriksdottir, G., Gobin, R., Seshasai, S.R., Forouhi, N.G., Gudnason, V., Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Medicine, 7, 2010, e1000278.
30. Schmermund, A., Möhlenkamp, S., Stang, A., Grönemeyer, D., Seibel, R., Hirche, H., Erbel, R., Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: Rationale and design of the Heinz Nixdorf Recall study. Risk factors, evaluation of coronary calcium and lifestyle. American Heart Journal 144 (2002), 212–218.
31. Selvin, E., Steffes, M.W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Brancati, F.L., Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. The New England Journal of Medicine 362 (2010), 800–811.
32. Spiegelman, D.D., Hertzmark, E.E., Easy SAS calculations for risk of prevalence ratios and differences. American Journal of Epidemiology 162 (2005), 199–200.
33. Stang, A., Moebus, S., Möhlenkamp, S., Dragano, N., Schmermund, A., Beck, E.M., Jöckel, K.H., Algorithms for converting random-zero to automated oscillometric blood pressure values, and vice versa. American Journal of Epidemiology 164 (2006), 85–94.
34. Sterne, J.A.C., Davey Smith, G., Sifting the evidence – what's wrong with significance tests?. BMJ 322 (2001), 226–231.
35. Tabak, A.G., Herder, C., Rathmann, W., Brunner, E.J., Kivimäki, M., Prediabetes: A high-risk state for diabetes development. Lancet 379 (2012), 2279–2290.
36. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 375 (2010), 2215–2222.
37. Von Scholten, B.J., Reinhard, H., Hansen, T.W., Lindhardt, M., Petersen, C.L., Wijnberg, N., Rossing, P., Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes. Cardiovascular Diabetology, 14, 2015, 59.
38. Von Scholten, B.J., Reinhard, H., Hansen, T.W., Schalkwijk, C.G., Stehouwer, C., Parving, H.H., Rossing P., Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetes patients with microalbuminuria. Journal of Diabetes and its Complications 30 (2016), 248–255.
39. Wong, N.D., Nelson, J.C., Granston, T., Bertoni, A.G., Blumenthal, R.S., Carr, J.J., Detrano, R., Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: The multiethnic study of atherosclerosis. JACC. Cardiovascular Imaging 5 (2012), 358–366.
40. World Health Organization, Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation [webpage on the internet], 2011, World Health Organization, Geneva (Available from: http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/. Accessed June 22, 2016).
41. Xing, F.Y.F., Neeland, I.J., Odette Gore, M., Ayers, C.R., Paixao, A.R., Turer, A.T., McGuire, D.K., Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: Observations from the Dallas heart study. Diabetes & Vascular Disease Research 11 (2014), 11–18.
42. Zeb, I., Budoff, M., Coronary artery calcium screening: Does it perform better than other cardiovascular risk stratification tools?. International Journal of Molecular Sciences 16 (2015), 6606–6620.